Correlation Between Caribou Biosciences and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and X4 Pharmaceuticals, you can compare the effects of market volatilities on Caribou Biosciences and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and X4 Pharmaceuticals.
Diversification Opportunities for Caribou Biosciences and X4 Pharmaceuticals
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Caribou and XFOR is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Caribou Biosciences and X4 Pharmaceuticals
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 0.48 times more return on investment than X4 Pharmaceuticals. However, Caribou Biosciences is 2.1 times less risky than X4 Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about 0.07 per unit of risk. If you would invest 109.00 in Caribou Biosciences on May 26, 2025 and sell it today you would earn a total of 76.00 from holding Caribou Biosciences or generate 69.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Caribou Biosciences vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Caribou Biosciences |
| X4 Pharmaceuticals |
Caribou Biosciences and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and X4 Pharmaceuticals
The main advantage of trading using opposite Caribou Biosciences and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Beam Therapeutics |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |